September 27, 2021
Dear Colleagues:
Together with the ATIP Grant Program Co-Chairs, Susan Dorsey, PhD, RN, FAAN and Peter Swaan, PhD, we are pleased to announce the sixth round of funding for the UMB ICTR Accelerated Translational Incubator Pilot (ATIP) Grant Program. The ATIP Grant program will provide starter funds for projects specifically focused on innovative,translational research that involve multi-disciplinary and inter-disciplinary collaborations among faculty from the Schools of Medicine, Pharmacy, Dentistry, Nursing, Law, and Social Work, UMBC, UMCP and UMB-community partnerships.
This Request for Proposals provides 12 months of funding (May 1, 2022 – April 30, 2023) for three types of ATIP opportunities: The ICTR Innovative Collaboration Pilot Grant, the ICTR Community-Engaged Research Grant and the ICTR Artificial Intelligence/Cybersecurity/Machine Learning Pilot Grant. Awards up to $35,000 will be funded.
Funding is through UMB’s and Johns Hopkins University’s (JHU) partnership in the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Clinical & Translational Science Awards (CTSA) Program, grant number 1UL1TR003098 or through the UMB ICTR internal funding mechanism.
To be considered for the UMB ICTR ATIP Grant Program opportunity, all proposals must be submitted electronically through the ICTR website
by 5 PM EST November 12, 2021. You can access the application and find out more information regarding this funding opportunity by visiting the
UMB ICTR ATIP RFA.
The University of Maryland, Baltimore Institute for Clinical and Translational Research (UMB ICTR) is a campus-wide clinical and translational research initiative supported by the UMB campus and the University of Maryland Medical System. The UMB ICTR provides financial support as well as infrastructure, environment, training, and work force development to invigorate, facilitate, and accelerate clinical and translational research to improve patient and community health. The ICTR would greatly appreciate if you would please forward this important funding opportunity announcement to your faculty.
Best,
Steve
Stephen N. Davis, MBBS, FRCP,FACE, MACP
Theodore E. Woodward Professor of Medicine
Professor of Physiology
Chairman, Department of Medicine
University of Maryland School of Medicine
Director, Institute of Clinical and Translational Research
Vice President of Clinical Translational Science
University of Maryland Baltimore
Physician-in-Chief
University of Maryland Medical Center
22 S. Greene Street, Room N3W42
Baltimore, MD 21201
